Skip to main content

Table 1 miRNAs correlated with OS of patients treated with temozolomide in TCGA

From: miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase

Variable Hazard ratio 95% CI p value
miR-130a 0.558 0.426–0.733 2.48 ∙ 10 −5
miR-222 1.341 1.166–1.541 3.65 ∙ 10 −5
miR-221 1.416 1.187–1.690 0.0001093
miR-20a 0.693 0.560–0.857 0.0007161
  1. CI, confidence interval.